Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
27.22
-0.30 (-1.09%)
Nov 17, 2026, 3:00 PM CST
Jiangsu Sinopep-Allsino Biopharmaceutical Employees
Jiangsu Sinopep-Allsino Biopharmaceutical had 2,360 employees as of December 31, 2025. The number of employees increased by 332 or 16.37% compared to the previous year. That makes Jiangsu Sinopep-Allsino Biopharmaceutical the 9,296th largest employer in the world and 1,956th in China.
Employees
2,360
Change (1Y)
332
Growth (1Y)
16.37%
Revenue / Employee
916.57K CNY
Profits / Employee
94.49K CNY
Market Cap
8.62B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,360 | 332 | 16.37% |
| Dec 31, 2024 | 2,028 | 483 | 31.26% |
| Dec 31, 2023 | 1,545 | 431 | 38.69% |
| Dec 31, 2022 | 1,114 | 23 | 2.11% |
| Dec 31, 2021 | 1,091 | 296 | 37.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Chengzhi | 4,462 |
| Shanghai Medicilon | 2,780 |
| Pacific Shuanglin Bio-pharmacy | 2,755 |
| Vcanbio Cell & Gene Engineering Corp., | 1,935 |
| Liaoning Chengda Biotechnology | 1,585 |
| Mabwell (Shanghai) Bioscience | 1,356 |
| Chongqing Genrix Biopharmaceutical | 1,133 |
| Hualan Biological Vaccine | 708 |